Hormone Quiz
How the Scales are Structured
Who Usually Takes This Test?
See How You Compare
Below is a preview of how scores are typically distributed across each scale.
Example Questions From the Test
- Lower estrogen can affect the moisture, elasticity, and condition of vaginal and urinary tissues
- FSH directly removes the protective lining of the bladder
- Testosterone causes all vaginal tissue to become thicker and less flexible
- Progesterone permanently increases blood sugar in vaginal tissue
- It is absent unless someone takes it as medication
- It is produced in smaller amounts by the ovaries and adrenal glands and contributes to functions such as sexual desire and musculoskeletal health
- It is another name for progesterone when that hormone is made by the adrenal glands
- It is produced only after menopause and has no role before then
- Pregnancy becomes impossible as soon as cycles start varying in length
- Hot flashes reliably indicate that ovulation has permanently ended
- Ovulation can still occur unpredictably, so pregnancy may remain possible until menopause
- Pregnancy is possible only during cycles that last exactly 28 days
Hormone Quiz - Description and methodology of the test
People who want a clearer grasp of menopause-related health information can use this assessment to check practical understanding rather than estimate a biological level. In that role, the hormone quiz helps readers review explanations, timelines, and everyday decisions before discussing concerns with a clinician. Its focus suits women seeking a hormone-focused quiz and a structured learning profile.
What This Assessment Explores
The questionnaire checks understanding of hormonal changes across perimenopause, menopause, and related health decisions. It suits readers reviewing symptoms, fertility, treatment, or testing without treating symptoms as a direct measure of hormone levels.
Questions connect estrogen, progesterone, testosterone, FSH, ovarian function, bone health, bleeding, temperature symptoms, contraception, and thyroid overlap. By examining what hormones do, the assessment functions as a hormone type quiz for learning rather than assigning a fixed category.
The result covers four dimensions:
- Core hormone knowledge shows understanding of major functions and changes.
- Menopause transitions show whether stages and patterns are distinguished.
- Symptom interpretation shows whether experiences receive plausible explanations.
- Health decisions show understanding of contraception, therapy, testing, and follow-up.
Together, these areas form an educational hormone imbalance quiz: the score identifies concepts to review and supports a clearer personal profile.
Methodology and Evidence Base
Each item presents one best answer with several alternatives. The task combines factual knowledge with applied scenarios about symptoms, reproductive timing, treatment, and follow-up. Its result reflects responses to these concepts rather than a separate symptom-severity or hormone-level measure.
Hormone Knowledge: 0-16 is interpreted through three displayed bands: Foundations to build (0-6), Developing knowledge (7-12), and Strong knowledge (13-16). These labels describe educational understanding. A reader can use the result as a menopause knowledge test to identify topics worth reviewing.
The content is conceptually consistent with the Menopause Knowledge Scale (Appling et al., 2000). It also addresses distinctions consistent with the North American Menopause Society’s 2022 position statement and reproductive-aging staging work by Harlow et al. (2012). This does not make the online questionnaire a validated adaptation of those sources.
No population norms, reliability coefficients, or clinical cutoffs are presented. Performance may reflect prior exposure, reading accuracy, current concerns, and willingness to choose carefully. The score is best read as a focused learning profile; persistent or concerning symptoms should be evaluated through individualized medical care.
- Appling, Susan E., Jerilyn K. Allen, Shirley Van Zandt, Sharon Olsen, Rosemarie Brager, and Jule Hallerdin. "Knowledge of Menopause and Hormone Replacement Therapy Use in Low-Income Urban Women." Journal of Women's Health & Gender-Based Medicine, 9(1), 57-64, 2000. 10.1089/152460900318975
- The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. "The 2022 Hormone Therapy Position Statement of The North American Menopause Society." Menopause, 29(7), 767-794, 2022. 10.1097/GME.0000000000002028
- Harlow, Siobán D., Margery Gass, Janet E. Hall, Roger Lobo, Pauline Maki, Robert W. Rebar, Sherry Sherman, Patrick M. Sluss, and Tobie J. de Villiers. "Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive Aging." Fertility and Sterility, 97(4), 843-851, 2012. 10.1016/j.fertnstert.2012.01.128